Products Antibodies Polyclonal Antibodies Anti-GP9 Polyclonal Antibody for WB, IHC-P, ELISA - P14770
Anti-GP9 Polyclonal Antibody for WB, IHC-P, ELISA - P14770

Polyclonal Antibodies

Anti-GP9 Polyclonal Antibody for WB, IHC-P, ELISA - P14770

Item Number : CM0029156

Price varies based on specs and customizations


Application
WB, IHC-P, ELISA
Cross Reactivity
Human, Mouse, Rat
Protein Weight
19kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name GP9 Rabbit pAb
Remarks/Alias GPIX; CD42a; GP9
Species Human
Gene ID 2815
Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 17-147 of human GP9 (NP_000165.1)
Source Rabbit
Category Polyclonal Antibodies
Application WB, IHC-P, ELISA
Cross Reactivity Human, Mouse, Rat
SWISS P14770
Protein Weight 19kDa
Shipping Ice bag

Biological Background: GP9 Function and Localization

  • Platelet glycoprotein IX (GP9), also designated GPIX or CD42a, is a membrane glycoprotein and an essential subunit of the GPIb-V-IX receptor complex on the platelet surface.
  • The GPIb-V-IX complex functions as the primary receptor for von Willebrand factor (vWF), mediating vWF-dependent platelet adhesion to exposed subendothelium at sites of vascular injury—a critical initiating step in hemostasis.
  • GP9 is thought to facilitate proper membrane insertion and orientation of the GPIb subunit within the complex, thereby supporting overall receptor stability and function.
  • It belongs to the leucine-rich repeat (LRR) protein family, characterized by tandem LRR motifs that often mediate protein-protein interactions.
  • GP9 is a transmembrane protein localized to the plasma membrane; its single-pass transmembrane domain anchors the complex in the platelet membrane.
  • Post-translational modifications include N-linked glycosylation (as a glycoprotein) and the formation of at least one disulfide bond, contributing to structural integrity.
  • Mutations in the GP9 gene are associated with Bernard-Soulier syndrome (BSS), an autosomal recessive bleeding disorder characterized by macrothrombocytopenia and defective platelet adhesion.
  • The protein participates in key biological processes such as blood coagulation, cell adhesion, and hemostasis, as highlighted by UniProt keywords.

Experimental Guidance and Technical Tips

  • The immunogen encompasses the extracellular domain (amino acids 17-147); the antibody may recognize both native and denatured GP9. For WB, consider testing under reducing and non-reducing conditions.
  • For IHC-P, target tissues rich in platelets or megakaryocytes (e.g., bone marrow, spleen) may show positive staining. Always include appropriate negative and positive controls.
  • Cross-reactivity with mouse and rat GP9 is reported; verify epitope conservation by sequence alignment if using in vivo models.
  • For ELISA, the recombinant protein fragment (aa 17-147) can serve as a positive control to assess antibody binding activity.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio serves as a comprehensive sourcing partner for IVD raw materials, connecting diagnostic manufacturers and laboratories with high-quality antibodies like this anti-GP9 polyclonal antibody. Beyond individual research reagents, we offer a broad portfolio of validated antibody pairs, optimized monoclonal and polyclonal antibodies, bulk ancillary reagents, and specialized raw-material sourcing for rare targets in platelet biology, hemostasis, and cardiovascular research. Let us streamline your supply chain from concept to clinic.

View more faqs for this product

Product Datasheet

Anti-GP9 Polyclonal Antibody for WB, IHC-P, ELISA - P14770


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!